Projekt

A multicenter, reandomized, double-blind, single-dose study to assess the effect of the combined inhalation of 150 ug indacaterol maleate (QAB149) and 50 ug glycopyrronium bromide (NVA237) versus inhaled 150 ug indacaterol maleate (QAB149) alone on inspiratory capacity in patients with moderate or severe COPD

Abgeschlossen · 2012 bis 2013